Lucira Covid-19 test is first to get FDA nod for home use
The authorization comes as Covid-19 testing demand threatens to swamp U.S. labs. However, it will take time for the Lucira test to become available nationwide.
The authorization comes as Covid-19 testing demand threatens to swamp U.S. labs. However, it will take time for the Lucira test to become available nationwide.
Everlywell, Nurx, and a bevy of other companies had begun marketing at-home tests as the U.S. still faces a shortage. But they had to stop after the Food and Drug Administration clarified that it had not approved at-home testing.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.